Feature: Biocurex Signs Abbott Labs - Licensing Deal Done.

Sep 18, 2021

/

03:00 PM PST

Rating

No ratings

Feature: Biocurex Signs Abbott Labs - Licensing Deal Done. Patience rewarded. Significant milestone achieved. Those two phrases encapsulate the importance of the joint announcement made today (release below) by biotech Biocurex (BOCX.PK) of the completio
Feature: Xtreme Delivers, Again.

Jul 9, 2020

/

01:13 PM PST

Rating

No ratings

Feature: Xtreme Delivers, Again. For the second time in a week, Xtreme Companies (OTCBB: XTME) has announced the sale of one of its Fire Rescue Watercraft through the Homeland Security Grant Program (HSGP) as a result of its efforts working with local an
Feature: MIV Therapeutics - A Stroke Stopping Acquisition.

Jul 9, 2020

/

01:13 PM PST

Rating

No ratings

Feature: MIV Therapeutics - A Stroke Stopping Acquisition. We don't usually publish two pieces on the same company within a week, however, substantive news can trump that practice. And this news is certainly applicable. We Alerted the readership to MIV T
Trading Alert: MIV Therapeutics - Superior Stents. Global Deal.

Jul 9, 2020

/

01:13 PM PST

Rating

No ratings

Trading Alert: MIV Therapeutics - Superior Stents. Global Deal. A few years ago, investors likely hadn't even heard of cardiac stents. And until now, they'd likely not heard of MIV Therapeutics (OTCBB: MIVT), either. We believe this smallcap company not
Feature: Xtreme - Takes on All Challengers.

Oct 31, 2020

/

10:53 PM PST

Rating

No ratings

Feature: Xtreme - Takes on all Challengers. If you needed any convincing that the recreational boat market is extremely buoyant, read our profile of MarineMax (NYSE: HZO) that we published on April 30th, 2003. The stock was $11 then, $33-plus now. And th
<<293  294  295  296  297  298  299  300  301  302  >>